High-resolution three-dimensional in vivo imaging of mouse oviduct using optical coherence tomography

Biomedical Optics Express

Volumn 6, Issue 7, 2015, Pages

  Burton, Jason C ^a   Wang, Shang ^a   Allison Stewart, C ^b   Behringer, Richard R ^b   Larina, Irina V ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALS; TOMOGRAPHY;

EMBRYONIC DEVELOPMENT; HIGH RESOLUTION IMAGE; MOLECULAR MECHANISM; MOLECULAR REGULATION; REPRODUCTIVE ORGANS; SPATIAL RESOLUTION; STRUCTURAL FEATURE; THREE DIMENSIONAL IMAGING;

OPTICAL TOMOGRAPHY;

ANIMAL TISSUE; ARTICLE; CUMULUS CELL; FEMALE; GENITAL SYSTEM; HISTOLOGY; MOUSE; NONHUMAN; OOCYTE; OPTICAL COHERENCE TOMOGRAPHY; OVIDUCT;

EID: 84946549916     PISSN: None     EISSN: 21567085     Source Type: Journal    
DOI: 10.1364/BOE.6.002713     Document Type: Article

References (46)

1. C. A. Stewart and R. R. Behringer, “Mouse oviduct development,” Results Probl. Cell Differ. 55, 247-262 (2012).
2. J. E. Ellington, “The bovine oviduct and its role in reproduction: a review of the literature,” Cornell Vet. 81(3), 313-328 (1991).
3. H. B. Croxatto, “Physiology of gamete and embryo transport through the fallopian tube,” Reprod. Biomed. Online 4(2), 160-169 (2002).
4. A. Bylander, M. Nutu, R. Wellander, M. Goksör, H. Billig, and D. G. J. Larsson, “Rapid effects of progesterone on ciliary beat frequency in the mouse fallopian tube,” Reprod. Biol. Endocrinol. 8(1), 48 (2010).
5. R. H. F. Hunter, The Fallopian tubes: Their Role in Fertility and Infertility (Springer-Verlag, 1988).
6. M. M. Matzuk and D. J. Lamb, “The biology of infertility: research advances and clinical challenges,” Nat. Med. 14(11), 1197-1213 (2008).
7. H. Wang and S. K. Dey, “Roadmap to embryo implantation: clues from mouse models,” Nat. Rev. Genet. 7(3), 185-199 (2006).
8. R. Shao, J. Hu, and H. Billig, “Toward understanding chlamydia infection-induced infertility caused by dysfunctional oviducts,” J. Infect. Dis. 208(4), 707-709 (2013).
9. M. Tuffrey, C. Woods, C. Inman, and M. Ward, “The effect of a single oral dose of azithromycin on chlamydial infertility and oviduct ultrastructure in mice,” J. Antimicrob. Chemother. 34(6), 989-999 (1994).
10. R. E. Dixon, S. J. Hwang, G. W. Hennig, K. H. Ramsey, J. H. Schripsema, K. M. Sanders, and S. M. Ward, “Chlamydia infection causes loss of pacemaker cells and inhibits oocyte transport in the mouse oviduct,” Biol. Reprod. 80(4), 665-673 (2009).
11. M.-W. Hu, Z.-B. Wang, H. Schatten, and Q.-Y. Sun, “New understandings on folliculogenesis/oogenesis regulation in mouse as revealed by conditional knockout,” J. Genet. Genomics 39(2), 61-68 (2012).
12. M. A. Fritz, “The modern infertility evaluation,” Clin. Obstet. Gynecol. 55(3), 692-705 (2012).
13. F. Petraglia, G. I. Serour, and C. Chapron, “The changing prevalence of infertility,” Int. J. Gynaecol. Obstet. 123(Suppl 2), S4-S8 (2013).
14. S. Kölle, S. Dubielzig, S. Reese, A. Wehrend, P. König, and W. Kummer, “Ciliary transport, gamete interaction, and effects of the early embryo in the oviduct: ex vivo analyses using a new digital videomicroscopic system in the cow,” Biol. Reprod. 81(2), 267-274 (2009).
15. G. Gonzalez and R. R. Behringer, “Dicer is required for female reproductive tract development and fertility in the mouse,” Mol. Reprod. Dev. 76(7), 678-688 (2009).
16. S. Pal, W. Hui, E. M. Peterson, and L. M. de la Maza, “Factors influencing the induction of infertility in a mouse model of Chlamydia trachomatis ascending genital tract infection,” J. Med. Microbiol. 47(7), 599-605 (1998).
17. S. S. Suarez, “Sperm transport and motility in the mouse oviduct: observations in situ,” Biol. Reprod. 36(1), 203-210 (1987).
18. S. Kölle, S. Reese, and W. Kummer, “New aspects of gamete transport, fertilization, and embryonic development in the oviduct gained by means of live cell imaging,” Theriogenology 73(6), 786-795 (2010).
19. D. Shi, K. Komatsu, M. Hirao, Y. Toyooka, H. Koyama, F. Tissir, A. M. Goffinet, T. Uemura, and T. Fujimori, “Celsr1 is required for the generation of polarity at multiple levels of the mouse oviduct,” Development 141(23), 4558-4568 (2014).
20. M. Komatsu and H. Fujita, “Electron-microscopic studies on the development and aging of the oviduct epithelium of mice,” Anat. Embryol. (Berl.) 152(3), 243-259 (1978).
21. M. C. Lee, T. C. Wu, Y. J. Wan, and I. Damjanov, “Pregnancy-related changes in the mouse oviduct and uterus revealed by differential binding of fluoresceinated lectins,” Histochemistry 79(3), 365-375 (1983).
22. D. Huang, E. A. Swanson, C. P. Lin, J. S. Schuman, W. G. Stinson, W. Chang, M. R. Hee, T. Flotte, K. Gregory, C. A. Puliafito, and et, “Optical coherence tomography,” Science 254(5035), 1178-1181 (1991).
23. W. Drexler, U. Morgner, R. K. Ghanta, F. X. Kärtner, J. S. Schuman, and J. G. Fujimoto, “Ultrahigh-resolution ophthalmic optical coherence tomography,” Nat. Med. 7(4), 502-507 (2001).
24. L. An and R. K. Wang, “In vivo volumetric imaging of vascular perfusion within human retina and choroids with optical micro-angiography,” Opt. Express 16(15), 11438-11452 (2008).
25. S. A. Boppart, W. Luo, D. L. Marks, and K. W. Singletary, “Optical coherence tomography: feasibility for basic research and image-guided surgery of breast cancer,” Breast Cancer Res. Treat. 84(2), 85-97 (2004).
26. B. J. Vakoc, D. Fukumura, R. K. Jain, and B. E. Bouma, “Cancer imaging by optical coherence tomography: preclinical progress and clinical potential,” Nat. Rev. Cancer 12(5), 363-368 (2012).
27. H. G. Bezerra, M. A. Costa, G. Guagliumi, A. M. Rollins, and D. I. Simon, “Intracoronary optical coherence tomography: a comprehensive review clinical and research applications,” JACC Cardiovasc. Interv. 2(11), 1035-1046 (2009).
28. B. E. Bouma, G. J. Tearney, H. Yabushita, M. Shishkov, C. R. Kauffman, D. DeJoseph Gauthier, B. D. MacNeill, S. L. Houser, H. T. Aretz, E. F. Halpern, and I. K. Jang, “Evaluation of intracoronary stenting by intravascular optical coherence tomography,” Heart 89(3), 317-320 (2003).
29. I. V. Larina, S. Ivers, S. Syed, M. E. Dickinson, and K. V. Larin, “Hemodynamic measurements from individual blood cells in early mammalian embryos with Doppler swept source OCT,” Opt. Lett. 34(7), 986-988 (2009).
30. G. Karunamuni, S. Gu, Y. Q. Doughman, A. I. Noonan, A. M. Rollins, M. W. Jenkins, and M. Watanabe, “Using optical coherence tomography to rapidly phenotype and quantify congenital heart defects associated with prenatal alcohol exposure,” Dev. Dyn. 244, 607-618 (2014).
31. A. M. Zysk, F. T. Nguyen, A. L. Oldenburg, D. L. Marks, and S. A. Boppart, “Optical coherence tomography: a review of clinical development from bench to bedside,” J. Biomed. Opt. 12(5), 051403 (2007).
32. J. G. Fujimoto, C. Pitris, S. A. Boppart, and M. E. Brezinski, “Optical coherence tomography: an emerging technology for biomedical imaging and optical biopsy,” Neoplasia 2(1-2), 9-25 (2000).
33. J. M. Herrmann, M. E. Brezinski, B. E. Bouma, S. A. Boppart, C. Pitris, J. F. Southern, and J. G. Fujimoto, “Two-and three-dimensional high-resolution imaging of the human oviduct with optical coherence tomography,” Fertil. Steril. 70(1), 155-158 (1998).
34. J. L. Fine, L. Kagemann, G. Wollstein, H. Ishikawa, and J. S. Schuman, “Direct Scanning of Pathology Specimens Using Spectral Domain Optical Coherence Tomography: A Pilot Study,” Ophthalmic Surg. Lasers Imaging 41(6), S58-S64 (2010).
35. M. Trottmann, S. Kolle, R. Leeb, D. Doering, S. Reese, C. G. Stief, K. Dulohery, M. Leavy, J. Kuznetsova, C. Homann, and R. Sroka, “Ex vivo investigations on the potential of optical coherence tomography (OCT) as a diagnostic tool for reproductive medicine in a bovine model,” J. Biophotonics (2015).
36. M. Kirillin, O. Panteleeva, E. Yunusova, E. Donchenko, and N. Shakhova, “Criteria for pathology recognition in optical coherence tomography of fallopian tubes,” J. Biomed. Opt. 17(8), 081413 (2012).
37. S. H. Syed, A. J. Coughlin, M. D. Garcia, S. Wang, J. L. West, K. V. Larin, and I. V. Larina, “Optical coherence tomography guided microinjections in live mouse embryos: high-resolution targeted manipulation for mouse embryonic research,” J. Biomed. Opt. 20(5), 051020 (2015).
38. L. M. Ittner and J. Götz, “Pronuclear injection for the production of transgenic mice,” Nat. Protoc. 2(5), 1206-1215 (2007).
39. L. Liu, J. A. Gardecki, S. K. Nadkarni, J. D. Toussaint, Y. Yagi, B. E. Bouma, and G. J. Tearney, “Imaging the Subcellular Structure of Human Coronary Atherosclerosis Using 1-μm Resolution Optical Coherence Tomography (μOCT),” Nat. Med. 17, 1010-1014 (2011).
40. V. V. Tuchin, Tissue Optics: Light Scattering Methods and Instruments for Medical Diagnosis (SPIE press Bellingham, 2007), Vol. 642.
41. S. Ishida and N. Nishizawa, “Quantitative comparison of contrast and imaging depth of ultrahigh-resolution optical coherence tomography images in 800-1700 nm wavelength region,” Biomed. Opt. Express 3(2), 282-294 (2012).
42. V. V. Tuchin, Optical Clearing of Tissues and Blood (SPIE Press Bellingham, 2006).
43. D. Zhu, K. V. Larin, Q. Luo, and V. V. Tuchin, “Recent progress in tissue optical clearing,” Laser Photon Rev 7(5), 732-757 (2013).
44. R. Huber, M. Wojtkowski, and J. G. Fujimoto, “Fourier Domain Mode Locking (FDML): A new laser operating regime and applications for optical coherence tomography,” Opt. Express 14(8), 3225-3237 (2006).
45. T. Klein, W. Wieser, L. Reznicek, A. Neubauer, A. Kampik, and R. Huber, “Multi-MHz retinal OCT,” Biomed. Opt. Express 4(10), 1890-1908 (2013).
46. P. Herz, Y. Chen, A. Aguirre, J. Fujimoto, H. Mashimo, J. Schmitt, A. Koski, J. Goodnow, and C. Petersen, “Ultrahigh resolution optical biopsy with endoscopic optical coherence tomography,” Opt. Express 12(15), 3532-3542 (2004).